Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Garofalo Health Care SpAMIL:GHC +1.92%88 3-Year EPS without NRI Growth Rate is 5.30% as of Jun. 2026, which is 49% below its 10-year median of 10.40. GuruFocus rates MIL:GHC with a GF Score™ of 88/100 and a GF Value™ of €5.75 (Fairly Valued). The stock has 4 warning signs investors should review. Among 502 Healthcare Providers & Services companies, Garofalo Health Care SpA ranks worse than 59.36% on this metric.
During the past 12 months, Garofalo Health Care SpA's average EPS without NRI Growth Rate was 11.00% per year.
During the past 3 years, the average EPS without NRI Growth Rate was 5.30% per year.
During the past 5 years, the average EPS without NRI Growth Rate was 10.50% per year.
During the past 10 years, the average EPS without NRI Growth Rate was 12.70% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
During the past 11 years, the highest 3-Year average EPS without NRI Growth Rate of Garofalo Health Care SpA was 35.30% per year. The lowest was -5.80% per year. And the median was 10.40% per year.
Garofalo Health Care SpA (MIL:GHC) 3-Year EPS without NRI Growth Rate Explanation
EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.
Garofalo Health Care SpA 3-Year EPS without NRI Growth Rate Related Terms
MIL:GHC vs HCA, THC, EHC: 3-Year EPS without NRI Growth Rate Comparison
For the Medical Care Facilities subindustry, Garofalo Health Care SpA's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Garofalo Health Care SpA 3-Year EPS without NRI Growth Rate vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Garofalo Health Care SpA's 3-Year EPS without NRI Growth Rate distribution charts can be found below:
* The bar in red indicates where Garofalo Health Care SpA's 3-Year EPS without NRI Growth Rate falls into.
Garofalo Health Care SpA 3-Year EPS without NRI Growth Rate Calculation
This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
What does a 3-Year EPS without NRI Growth Rate of 5.30% mean?
Garofalo Health Care SpA (MIL:GHC) has a 3-Year EPS without NRI Growth Rate of 5.30% as of Jun. 2026. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for Garofalo Health Care SpA and its competitors. This is 49% below median its historical median of 10.40. According to the industry distribution chart, Garofalo Health Care SpA ranks #298 out of 502 companies in the Healthcare Providers & Services industry, placing it in the top 59.4%.
Is Garofalo Health Care SpA's 3-Year EPS without NRI Growth Rate too high?
Garofalo Health Care SpA's current 3-Year EPS without NRI Growth Rate of 5.30% is 49% below median its 10-year median of 10.40. The Healthcare Providers & Services industry median 3-Year EPS without NRI Growth Rate is 10.90. Garofalo Health Care SpA's value of 5.30% is 51.4% below this industry median. Based on the distribution chart, Garofalo Health Care SpA ranks #298 out of 502 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Garofalo Health Care SpA has a GF Score™ of 88/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Garofalo Health Care SpA's 3-Year EPS without NRI Growth Rate compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Garofalo Health Care SpA ranks #298 out of 502 companies for 3-Year EPS without NRI Growth Rate. This places Garofalo Health Care SpA in the lower half of its industry. The industry median 3-Year EPS without NRI Growth Rate is 10.90. Garofalo Health Care SpA's value of 5.30% is 51.4% below this benchmark. While the company's 10-year median is 10.40 vs. the industry median of 10.90, Garofalo Health Care SpA has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EPS without NRI Growth Rate for a Healthcare Providers & Services company?
The median 3-Year EPS without NRI Growth Rate among Healthcare Providers & Services companies is 10.90, based on 502 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EPS without NRI Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EPS without NRI Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Garofalo Health Care SpA's current 3-Year EPS without NRI Growth Rate of 5.30% is 51.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EPS without NRI Growth Rate mean?
A high 3-Year EPS without NRI Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for Garofalo Health Care SpA and its competitors. For the Healthcare Providers & Services industry, the median 3-Year EPS without NRI Growth Rate is 10.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Garofalo Health Care SpA's current 3-Year EPS without NRI Growth Rate is 5.30%, which is 49% below median its own 10-year median of 10.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Garofalo Health Care SpA stock overvalued right now?
Based on GuruFocus' analysis, Garofalo Health Care SpA (MIL:GHC) is currently considered Fairly Valued. The stock's GF Value™ is €5.75, compared to a current price of €5.30 — trading 7.8% below its estimated fair value. The current 3-Year EPS without NRI Growth Rate is 5.30%, which is 49% below median its 10-year median of 10.40 and 51.4% below the Healthcare Providers & Services industry median of 10.90. Garofalo Health Care SpA's overall GF Score™ is 88/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EPS without NRI Growth Rate calculated?
3-Year EPS without NRI Growth Rate is calculated from a company's financial statements. For Garofalo Health Care SpA (MIL:GHC), the current 3-Year EPS without NRI Growth Rate is 5.30% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Garofalo Health Care SpA (MIL:GHC) Overvalued in 2026?
Based on GuruFocus' analysis, Garofalo Health Care SpA stock appears to be undervalued.
The current stock price of €5.30 is trading 7.8% below its estimated GF Value™ of €5.75.
GuruFocus considers Garofalo Health Care SpA to be Fairly Valued.
Key valuation signals for MIL:GHC:
3-Year EPS without NRI Growth Rate: 5.30% (49% below median its 10-year median of 10.40)
GF Value™: €5.75 vs. price of €5.30 (7.8% below fair value)
Industry Position: 51.4% below the Healthcare Providers & Services median (#298 of 502)
No single metric tells the full story. See the MIL:GHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Garofalo Health Care SpA is an Italian accredited private healthcare provider offering a comprehensive range of services across various areas of healthcare through diversified specialties, supported by the use of technologies and qualified personnel. The Group mainly operates in regions of northern and central Italy, which have been selected based on their attractiveness in terms of per capita healthcare spending, above-average per capita income, and well-developed internal transport infrastructure.
88GF Score
Get the complete analysis for MIL:GHC
3-Year EPS without NRI Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:GHC has been successfully added to your 
